Rare Disease Trial, Recruiting (NCT04758325)

Rare Disease Trial, Recruiting NCT04758325 Sponsor: Prof. Dr. Richard F Schlenk Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04758325 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with, or doctors suspect you may have, a soft-tissue or bone sarcoma (a type of cancer affecting soft tissues or bones)
You are 12 years old or older
You are able to understand what the registry involves and what it means for you personally
You are able and willing to sign a written consent form
You are mentally and physically able to give your own consent to take part

Who may not be able to join:

You have a serious neurological (brain or nervous system) or psychiatric (mental health) condition that makes it impossible for you to give written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard F. Schlenk, Prof.Dr.med, National Center for Tumour Disease

Phone: +49 6221 56 6228

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04758325

Sponsor: Prof. Dr. Richard F Schlenk

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: +49 6221 56 6228

More information: https://clinicaltrials.gov/study/NCT04758325

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with, or doctors suspect you may have, a soft-tissue or bone sarcoma (a type of cancer affecting soft tissues or bones)
You are 12 years old or older
You are able to understand what the registry involves and what it means for you personally
You are able and willing to sign a written consent form
You are mentally and physically able to give your own consent to take part

Who may not be able to join:

You have a serious neurological (brain or nervous system) or psychiatric (mental health) condition that makes it impossible for you to give written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Prof. Dr. Richard F Schlenk

Registry

ClinicalTrials.gov

Start date

23 July 2019

Est. completion

1 July 2030

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

overall survival; overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov